Cointime

Ykrita Life Sciences

company

About

YLS develops a medical device to help clinicians treat patients without the need for an organ transplant & hospitalisation.

Highlights

Total Funding Amount
$1.20M
Funding Rounds
1
Investors
2

Details

Last Funding Type
Seed
Last Funding Money Raised
$1.20M
Industries
Health Care,Life Science,Medical,Medical Device
Founded date
Jan 1, 2020
Operating Status
Active

YLS is developing a bio-medical device: Bio-engineered Artificial Ectopic Liver (BAEL), aimed at helping clinicians to treat patients suffering from liver failure while eliminating the need for an organ transplant, hospitalization, and exorbitant expenditure on the treatment.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.20M
Ykrita Life Sciences has raised a total of $1.20M in funding over 2 rounds. Their latest funding was raised on Nov 30, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 30, 2021 Seed $1.20M 2 Venture Catalysts
Indian Scientific Innovation Company 		— Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Ykrita Life Sciences is funded by 2 investors. Venture Catalysts and Indian Scientific Innovation Company are the most recent investors.
Investor Name Lead Investor Funding Round
Venture Catalysts Yes Seed
Indian Scientific Innovation Company Yes Seed
Cointime
เนื้อหา
บริษัท